391 related articles for article (PubMed ID: 33262577)
1. Comparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions.
Li Q; Huo H; Hu W; Sui Y; Tang Y
Drug Des Devel Ther; 2020; 14():5167-5177. PubMed ID: 33262577
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
5. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.
Bai W; Sun X; Qiu B; Guo C; Song H; Hu Y; Zhang X; Yin P; Wang X; Dong Z
Drug Des Devel Ther; 2024; 18():2273-2285. PubMed ID: 38895175
[TBL] [Abstract][Full Text] [Related]
7. A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects.
Feng J; Kuang SY; Wan JH; Li R; Zhu YJ; Cai BL; Guan L; Zhang Z
Int J Clin Pharmacol Ther; 2024 Jun; 62(6):284-292. PubMed ID: 38577751
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Zhai Y; Wu L; Zheng Y; Wu M; Huang Y; Huang Q; Shentu J; Zhao Q; Liu J
Drug Des Devel Ther; 2020; 14():3131-3142. PubMed ID: 32801649
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of a Generic Nateglinide Formulation in Healthy Chinese Volunteers under Fasting and Fed Conditions: A Randomized, Open-Label, Double-Cycle, Double-Crossover Study.
Yu M; Li X; Jin H; Chen L; Wang N; Wang H; Cao Y; Sui X; Gao X; Yang H; Wang W
Pharmacology; 2021; 106(7-8):418-425. PubMed ID: 33866315
[TBL] [Abstract][Full Text] [Related]
11. Comparison of scaled-average, population, and individual bioequivalence on 2 tablets of pitavastatin calcium: a 3-period, reference-replicated, crossover study in healthy Chinese volunteers.
Huang YH; Li ZQ; Pan GX; Li YF; Liu Y; Sun JX; Gu XF; Li N; Wang BH
Clin Ther; 2014 Sep; 36(9):1205-1216.e6. PubMed ID: 25234550
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Chen Y; Ye L; Mei J; Tian M; Xu M; Jin Q; Yu X; Yang S; Wang J
Drugs R D; 2024 May; ():. PubMed ID: 38811485
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
17. A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
Liu Y; Cheng J; Liang L; Qian W; Ou M; Zhang M; Wang Y; Wang Y; Peng K; Jia J
PLoS One; 2023; 18(4):e0284576. PubMed ID: 37083730
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke
Sun ML; Liu C; Bai HH; Wei YL; Zhang W; Liu HJ; Li YJ; Liu L; Wang Y; Tong YX; Gao Q; Liu QY; Wang X
Ann Med; 2022 Dec; 54(1):2626-2635. PubMed ID: 36135935
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Bai W; Song H; Hu Y; Zhang X; Wang X; Guo C; Qiu B; Dong Z
Drug Des Devel Ther; 2023; 17():3035-3046. PubMed ID: 37795495
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions.
Li Q; Jia L; Hu W; Dong S; Cai C
Drug Des Devel Ther; 2021; 15():2551-2562. PubMed ID: 34163141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]